{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:59:34Z","timestamp":1793325574241,"version":"4.5.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["CA270147"],"award-info":[{"award-number":["CA270147"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bmcl.2025.130395","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T18:14:48Z","timestamp":1757096088000},"page":"130395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["TRAP1 and its therapeutic potential"],"prefix":"10.1016","volume":"129","author":[{"given":"Andrew","family":"Gutierrez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Archdeacon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian S.J.","family":"Blagg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2025.130395_bb0005","doi-asserted-by":"crossref","DOI":"10.1126\/science.aac4354","article-title":"In vivo aspects of protein folding and quality control","volume":"353","author":"Balchin","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.bmcl.2025.130395_bb0010","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.cell.2012.06.047","article-title":"Quantitative analysis of Hsp90-client interactions reveals principles of substrate recognition","volume":"150","author":"Taipale","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bmcl.2025.130395_bb0015","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nature10317","article-title":"Molecular chaperones in protein folding and proteostasis","volume":"475","author":"Hartl","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2025.130395_bb0020","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nrc1716","article-title":"HSP90 and the chaperoning of cancer","volume":"5","author":"Whitesell","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bmcl.2025.130395_bb0025","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nature01913","article-title":"A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors","volume":"425","author":"Kamal","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2025.130395_bb0030","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/35050618","article-title":"The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins","volume":"3","author":"Connell","year":"2001","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.bmcl.2025.130395_bb0035","doi-asserted-by":"crossref","first-page":"14536","DOI":"10.1073\/pnas.93.25.14536","article-title":"Pharmacologic shifting of a balance between protein refolding and degradation mediated by Hsp90","volume":"93","author":"Schneider","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmcl.2025.130395_bb0040","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/jmcb\/mjz048","article-title":"The molecular chaperone Hsp90\u03b1 deficiency causes retinal degeneration by disrupting Golgi organization and vesicle transportation in photoreceptors","volume":"12","author":"Wu","year":"2020","journal-title":"J Mol Cell Biol"},{"key":"10.1016\/j.bmcl.2025.130395_bb0045","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1021\/mp300138n","article-title":"The hERG channel is dependent upon the Hsp90\u03b1 isoform for maturation and trafficking","volume":"9","author":"Peterson","year":"2012","journal-title":"Mol Pharm"},{"key":"10.1016\/j.bmcl.2025.130395_bb0050","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1074\/jbc.275.5.3305","article-title":"The hsp90-related protein TRAP1 is a mitochondrial protein with distinct functional properties","volume":"275","author":"Felts","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2025.130395_bb0055","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2174\/13894501113149990015","article-title":"Hypoxia-inducible factor-1 (HIF-1): a potential target for intervention in ocular neovascular diseases","volume":"14","author":"Vadlapatla","year":"2013","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.bmcl.2025.130395_bb0060","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.bmcl.2018.05.031","article-title":"New TRAP1 and Hsp90 chaperone inhibitors with cationic components: preliminary studies on mitochondrial targeting","volume":"28","author":"Rondanin","year":"2018","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2025.130395_bb0065","doi-asserted-by":"crossref","first-page":"10043","DOI":"10.1021\/acs.chemrev.7b00042","article-title":"Mitochondria-targeted Triphenylphosphonium-based compounds: syntheses, mechanisms of action, and therapeutic and diagnostic applications","volume":"117","author":"Zielonka","year":"2017","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmcl.2025.130395_bb0070","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13000-017-0598-3","article-title":"Clinicopathologic significance of TRAP1 expression in colorectal cancer: a large scale study of human colorectal adenocarcinoma tissues","volume":"12","author":"Pak","year":"2017","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.bmcl.2025.130395_bb0075","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2353\/ajpath.2010.090521","article-title":"Cytoprotective mitochondrial chaperone TRAP-1 as a novel molecular target in localized and metastatic prostate cancer","volume":"176","author":"Leav","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bmcl.2025.130395_bb0080","first-page":"13090","article-title":"Expression of tumor necrosis factor receptor-associated protein 1 and its clinical significance in kidney cancer","volume":"8","author":"Si","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.bmcl.2025.130395_bb0085","doi-asserted-by":"crossref","DOI":"10.1111\/eci.12900","article-title":"TRAP1 regulates autophagy in lung cancer cells","volume":"48","author":"Barbosa","year":"2018","journal-title":"Eur J Clin Investig"},{"key":"10.1016\/j.bmcl.2025.130395_bb0090","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/15384047.2022.2029132","article-title":"Feasibility and safety of targeting mitochondria for cancer therapy \u2013 preclinical characterization of gamitrinib, a first-in-class, mitochondriaL-targeted small molecule Hsp90 inhibitor","volume":"23","author":"Hayat","year":"2022","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.bmcl.2025.130395_bb0095","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of Cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bmcl.2025.130395_bb0100","article-title":"The mitochondrial chaperone TRAP1 as a candidate target of oncotherapy","volume":"10","author":"Xie","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.bmcl.2025.130395_bb0105","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12915-020-0740-7","article-title":"The mitochondrial HSP90 paralog TRAP1 forms an OXPHOS-regulated tetramer and is involved in mitochondrial metabolic homeostasis","volume":"18","author":"Joshi","year":"2020","journal-title":"BMC Biol"},{"key":"10.1016\/j.bmcl.2025.130395_bb0110","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3390\/biom10010135","article-title":"Modulation of mitochondrial metabolic reprogramming and oxidative stress to overcome Chemoresistance in Cancer","volume":"10","author":"Avolio","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.bmcl.2025.130395_bb0115","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.mito.2023.02.011","article-title":"The mitochondrial chaperone TRAP-1 regulates the glutamine metabolism in tumor cells","volume":"69","author":"Dharaskar","year":"2023","journal-title":"Mitochondrion"},{"key":"10.1016\/j.bmcl.2025.130395_bb0120","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.bbrc.2020.05.204","article-title":"Cyclophilin D counterbalances mitochondrial calcium uniporter-mediated brain mitochondrial calcium uptake","volume":"529","author":"Zhang","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmcl.2025.130395_bb0125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ygyno.2009.10.078","article-title":"Heat shock proteins, cell survival and drug resistance: the mitochondrial chaperone TRAP1, a potential novel target for ovarian cancer therapy","volume":"117","author":"Landriscina","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bmcl.2025.130395_bb0130","doi-asserted-by":"crossref","first-page":"11897","DOI":"10.18632\/oncotarget.2472","article-title":"Inhibition of succinate dehydrogenase by the mitochondrial chaperone TRAP1 has anti-oxidant and anti-apoptotic effects on tumor cells","volume":"5","author":"Guzzo","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.bmcl.2025.130395_bb0135","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.cmet.2013.04.019","article-title":"The mitochondrial chaperone TRAP1 promotes neoplastic growth by inhibiting succinate dehydrogenase","volume":"17","author":"Sciacovelli","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.bmcl.2025.130395_bb0140","doi-asserted-by":"crossref","first-page":"7816","DOI":"10.18632\/oncotarget.6868","article-title":"Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanoma","volume":"7","author":"Hu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bmcl.2025.130395_bb0145","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/path.4936","article-title":"TRAP1 controls cell cycle G2-M transition through the regulation of CDK1 and MAD2 expression\/ubiquitination","volume":"243","author":"Sisinni","year":"2017","journal-title":"J Pathol"},{"key":"10.1016\/j.bmcl.2025.130395_bb0150","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1021\/ja511893n","article-title":"Development of a mitochondria-targeted Hsp90 inhibitor based on the crystal structures of human TRAP1","volume":"137","author":"Lee","year":"2015","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2025.130395_bb0155","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1021\/acs.jmedchem.9b01420","article-title":"Dual binding to Orthosteric and allosteric sites enhances the anticancer activity of a TRAP1-targeting drug","volume":"63","author":"Hu","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130395_bb0160","doi-asserted-by":"crossref","first-page":"19684","DOI":"10.1021\/jacs.1c07099","article-title":"Mitoquinone inactivates mitochondrial chaperone TRAP1 by blocking the client binding site","volume":"143","author":"Yoon","year":"2021","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2025.130395_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114052","article-title":"Synthesis and antiproliferative activity of 6BrCaQ-TPP conjugates for targeting the mitochondrial heat shock protein TRAP1","volume":"229","author":"Mathieu","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130395_bb0170","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.1021\/acs.jmedchem.7b00978","article-title":"Paralog specificity determines subcellular distribution, action mechanism, and anticancer activity of TRAP1 inhibitors","volume":"60","author":"Park","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130395_bb0175","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1089\/ars.2019.7972","article-title":"Honokiol Bis-Dichloroacetate is a selective allosteric inhibitor of the mitochondrial chaperone TRAP1","volume":"34","author":"Sanchez-Martin","year":"2021","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.bmcl.2025.130395_bb0180","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1002\/pmic.201100242","article-title":"Concomitant inhibition of HSP90, its mitochondrial localized homologue TRAP1 and HSP27 by green tea in pancreatic Cancer HPAF-II cells","volume":"11","author":"Zhang","year":"2011","journal-title":"Proteomics"},{"key":"10.1016\/j.bmcl.2025.130395_bb0185","author":"Anonymous"},{"key":"10.1016\/j.bmcl.2025.130395_bb0190","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.canlet.2009.01.018","article-title":"TRAP1, a novel mitochondrial chaperone responsible for multi-drug resistance and protection from apoptotis in human colorectal carcinoma cells","volume":"279","author":"Costantino","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bmcl.2025.130395_bb0195","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1080\/10253890701314863","article-title":"Tumor necrosis factor-associated protein 1 (TRAP-1) protects cells from oxidative stress and apoptosis","volume":"10","author":"Montesano Gesualdi","year":"2007","journal-title":"Stress"},{"key":"10.1016\/j.bmcl.2025.130395_bb0200","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ccr.2005.03.035","article-title":"Rational design of shepherdin, a novel anticancer agent","volume":"7","author":"Plescia","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bmcl.2025.130395_bb0205","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.chembiol.2007.11.002","article-title":"Hsp90 inhibitors disrupt mitochondrial homeostasis in Cancer cells","volume":"14","author":"Neckers","year":"2007","journal-title":"Chem Biol"},{"key":"10.1016\/j.bmcl.2025.130395_bb0210","doi-asserted-by":"crossref","first-page":"227","DOI":"10.31083\/j.fbl2809227","article-title":"Inhibition of TRAP1 accelerates the DNA damage response, activation of the heat shock response and metabolic reprogramming in colon cancer cells","volume":"28","author":"Bhasin","year":"2023","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1016\/j.bmcl.2025.130395_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215915","article-title":"Metabolic targeting of NRF2 potentiates the efficacy of the TRAP1 inhibitor G-TPP through reduction of ROS detoxification in colorectal cancer","volume":"549","author":"Tsai","year":"2022","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bmcl.2025.130395_bb0220","doi-asserted-by":"crossref","first-page":"6693","DOI":"10.1158\/0008-5472.CAN-14-1331","article-title":"TRAP1 is involved in BRAF regulation and downstream attenuation of ERK phosphorylation and cell-cycle progression: a novel target for BRAF-mutated colorectal tumors","volume":"74","author":"Condelli","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.bmcl.2025.130395_bb0225","doi-asserted-by":"crossref","first-page":"22298","DOI":"10.18632\/oncotarget.4263","article-title":"Targeting TRAP1 as a downstream effector of BRAF cytoprotective pathway: a novel strategy for human BRAF-driven colorectal carcinoma","volume":"6","author":"Condelli","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bmcl.2025.130395_bb0230","doi-asserted-by":"crossref","unstructured":"Zhang, G.; Frederick, D. T.; Wu, L.; et al. Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors. J Clin Invest , 126, 1834\u20131856.","DOI":"10.1172\/JCI82661"},{"key":"10.1016\/j.bmcl.2025.130395_bb0235","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.3892\/etm.2021.10681","article-title":"Suppressing TRAP1 sensitizes glioblastoma multiforme cells to temozolomide","volume":"22","author":"Wang","year":"2021","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.bmcl.2025.130395_bb0240","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3390\/cancers11060788","article-title":"Activation of LXR receptors and inhibition of TRAP1 causes synthetic lethality in solid tumors","volume":"11","author":"Nguyen","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bmcl.2025.130395_bb0245","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.3390\/cells9071661","article-title":"Inhibition of HDAC1\/2 along with TRAP1 causes synthetic lethality in glioblastoma model systems","volume":"9","author":"Nguyen","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bmcl.2025.130395_bb0250","author":"Anonymous"},{"key":"10.1016\/j.bmcl.2025.130395_bb0255","doi-asserted-by":"crossref","first-page":"112184","DOI":"10.18632\/oncotarget.23097","article-title":"A mitochondrial-targeted purine-based HSP90 antagonist for leukemia therapy","volume":"8","author":"Bryant","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bmcl.2025.130395_bb0260","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1530\/ERC-16-0063","article-title":"TRAP1 regulates cell cycle and apoptosis in thyroid carcinoma cells","volume":"23","author":"Palladino","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.bmcl.2025.130395_bb0265","author":"Anonymous"},{"key":"10.1016\/j.bmcl.2025.130395_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105856","article-title":"Triphenylphosphonium conjugation to a TRAP1 inhibitor, 2-amino-6-chloro-7,9-dihydro-8H-purin-8-one increases antiproliferative activity","volume":"126","author":"Yang","year":"2022","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2025.130395_bb0275","author":"Anonymous"},{"key":"10.1016\/j.bmcl.2025.130395_bb0280","doi-asserted-by":"crossref","first-page":"25247","DOI":"10.1074\/jbc.M116.745950","article-title":"Transgenic expression of the mitochondrial chaperone TNFR-associated protein 1 (TRAP1) accelerates prostate Cancer development","volume":"291","author":"Lisanti","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2025.130395_bb0285","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s12276-019-0360-x","article-title":"Unleashing the full potential of Hsp90 inhibitors as cancer therapeutics through simultaneous inactivation of Hsp90, Grp94, and TRAP1","volume":"52","author":"Park","year":"2020","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.bmcl.2025.130395_bb0290","author":"Anonymous"},{"key":"10.1016\/j.bmcl.2025.130395_bb0295","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1158\/1541-7786.MCR-13-0481","article-title":"TRAP1 regulates proliferation, mitochondrial function and has prognostic significance in NSCLC","volume":"12","author":"Agorreta","year":"2014","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.bmcl.2025.130395_bb0300","first-page":"2187","article-title":"TRAP1 inhibition increases glutamine Synthetase activity in glutamine auxotrophic non-small cell lung Cancer cells","volume":"38","author":"Vo","year":"2018","journal-title":"Anticancer Res"},{"key":"10.1016\/j.bmcl.2025.130395_bb0305","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.bmcl.2025.130395_bb0310","doi-asserted-by":"crossref","first-page":"44495","DOI":"10.18632\/oncotarget.6252","article-title":"Aberrantly upregulated TRAP1 is required for tumorigenesis of breast cancer","volume":"6","author":"Zhang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bmcl.2025.130395_bb0315","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.10468","article-title":"Identification and characterization of critical genes associated with tamoxifen resistance in breast cancer","volume":"8","author":"Zhang","year":"2020","journal-title":"PeerJ"},{"key":"10.1016\/j.bmcl.2025.130395_bb0320","first-page":"7","article-title":"The chaperone TRAP1 as a modulator of the mitochondrial adaptations in Cancer cells","author":"Masgras","year":"2017","journal-title":"Front Oncol"},{"key":"10.1016\/j.bmcl.2025.130395_bb0325","doi-asserted-by":"crossref","first-page":"20553","DOI":"10.1074\/jbc.M703196200","article-title":"Heat shock protein 75 (TRAP1) antagonizes reactive oxygen species generation and protects cells from Granzyme M-mediated apoptosis *","volume":"282","author":"Hua","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2025.130395_bb0330","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/cns.13549","article-title":"Quality of life in Parkinson\u2019s disease: a systematic review and meta-analysis of comparative studies","volume":"27","author":"Zhao","year":"2020","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.bmcl.2025.130395_bb0335","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13024-023-00676-7","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease \u2013 a key disease hallmark with therapeutic potential","volume":"18","author":"Henrich","year":"2023","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.bmcl.2025.130395_bb0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0050172","article-title":"PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1","volume":"5","author":"Pridgeon","year":"2007","journal-title":"PLoS Biol"},{"key":"10.1016\/j.bmcl.2025.130395_bb0345","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.205","article-title":"Drosophila Trap1 protects against mitochondrial dysfunction in a PINK1\/parkin model of Parkinson\u2019s disease","volume":"4","author":"Costa","year":"2013","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.bmcl.2025.130395_bb0350","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1074\/jbc.M115.656934","article-title":"Tumor necrosis factor receptor-associated protein 1 (TRAP1) mutation and TRAP1 inhibitor Gamitrinib-triphenylphosphonium (G-TPP) induce a Forkhead box O (FOXO)-dependent cell protective signal from mitochondria","volume":"291","author":"Kim","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2025.130395_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.107948","article-title":"Approaches to develop therapeutics to treat frontotemporal dementia","volume":"166","author":"Elia","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bmcl.2025.130395_bb0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-021-03716-6","article-title":"HIF1\u03b1-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia","volume":"12","author":"Laquatra","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.bmcl.2025.130395_bb0365","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.3390\/antiox10111829","article-title":"TRAP1 in oxidative stress and neurodegeneration","volume":"10","author":"Ramos Rego","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.bmcl.2025.130395_bb0370","doi-asserted-by":"crossref","unstructured":"Duh, E. J.; Sun, J. K.; Stitt, A. W. Diabetic retinopathy: current understanding, mechanisms, and treatment strategies. JCI Insight, 2, e93751.","DOI":"10.1172\/jci.insight.93751"},{"key":"10.1016\/j.bmcl.2025.130395_bb0375","doi-asserted-by":"crossref","first-page":"2302776","DOI":"10.1002\/advs.202302776","article-title":"Targeting the mitochondrial chaperone TRAP1 alleviates vascular pathologies in ischemic retinopathy","volume":"11","author":"Kim","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.bmcl.2025.130395_bb0380","series-title":"Mitochondrial chaperone tumour necrosis factor receptor-associated protein 1 protects cardiomyocytes from hypoxic injury by regulating mitochondrial permeability transition pore opening \u2013 PubMed","author":"Anonymous","year":"2025"},{"key":"10.1016\/j.bmcl.2025.130395_bb0385","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2019.01.001","article-title":"US renal data system 2018 annual data report: epidemiology of kidney disease in the United States","volume":"73","author":"Saran","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.bmcl.2025.130395_bb0390","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nrneph.2017.107","article-title":"Mitochondrial energetics in the kidney","volume":"13","author":"Bhargava","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.bmcl.2025.130395_bb0395","first-page":"6431517","article-title":"Tumor necrosis factor receptor-associated protein 1 protects against mitochondrial injury by preventing high glucose-induced mPTP opening in diabetes","volume":"2020","author":"Liu","year":"2020","journal-title":"Oxidative Med Cell Longev"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2500304X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2500304X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T16:18:25Z","timestamp":1785169105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X2500304X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":79,"alternative-id":["S0960894X2500304X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130395","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TRAP1 and its therapeutic potential","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130395","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"130395"}}